OTV is a venture capital firm investing globally in early and mid-growth-stage digital health startups, with offices in New York and Tel Aviv and Asia Pacific connectivity through Shanghai. It backs founders building innovations that improve diagnosis, treatments and wellbeing, with portfolio exposure across HealthTech, medical devices, biotechnology, pharmaceuticals and AI-enabled healthcare. The firm has closed a $170 million fund.